• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与家族性甲状腺髓样癌相关的V804M突变型RET原癌基因的特征分析:最大的土耳其家族报告

Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.

作者信息

Basaran M N, Tuna M M, Karakılıç E, Doğan B A, İmga N N, Berker D, Güler S

机构信息

Endocrinology and Metabolism Department, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Endocrinology and Metabolism Department, Dicle University Medical Faculty, Sur, Diyarbakır, Turkey.

出版信息

J Endocrinol Invest. 2015 May;38(5):541-6. doi: 10.1007/s40618-014-0224-0. Epub 2014 Dec 12.

DOI:10.1007/s40618-014-0224-0
PMID:25501606
Abstract

PURPOSE

Analysis of the RET proto-oncogen is very important for diagnosis and prognosis of medullary thyroid cancer (MTC). Genotype-phenotype correlation is also well known. Here we report features of the largest known family in Turkey with the V804M-mutated RET proto-oncogene.

METHODS

Thirty members from three generations were evaluated. A RET proto-oncogen mutation, calcitonin (Ct) measurement and thyroid ultrasound were performed on all individuals. Seventeen members had V804M mutation. Fourteen of these patients underwent total thyroidectomy and additional central lymph node dissection for five subjects.

RESULTS

The mean age of patients with MTC was 46.5 (30-61) years. The mean calcitonin level of RET positive members was 13.27 pg/mL (1-49.8 pg/mL). Three had a basal Ct level above normal limits. Seven of the 14 patients were diagnosed with MTC, and two were diagnosed with papillary thyroid cancer without MTC. One patient had central neck metastasis. Hyperparathyroidism or pheochromocytoma was not detected in any case. Patients who were RET negative, had normal Ct levels and no suspected nodule on ultrasound examination.

CONCLUSIONS

Our study revealed a relatively good prognosis in patients with V804M mutation. Despite the surgery was performed in older age no advance disease was observed.

摘要

目的

RET原癌基因分析对甲状腺髓样癌(MTC)的诊断和预后非常重要。基因型与表型的相关性也广为人知。在此,我们报告土耳其已知的携带V804M突变的RET原癌基因的最大家族的特征。

方法

对三代中的30名成员进行了评估。对所有个体进行了RET原癌基因突变检测、降钙素(Ct)测量和甲状腺超声检查。17名成员存在V804M突变。其中14名患者接受了全甲状腺切除术,5名患者还进行了中央区淋巴结清扫。

结果

MTC患者的平均年龄为46.5(30 - 61)岁。RET阳性成员的平均降钙素水平为13.27 pg/mL(1 - 49.8 pg/mL)。3人的基础Ct水平高于正常范围。14名患者中有7人被诊断为MTC,2人被诊断为无MTC的甲状腺乳头状癌。1例患者有颈部中央区转移。未发现任何一例甲状旁腺功能亢进或嗜铬细胞瘤。RET阴性的患者Ct水平正常,超声检查未发现可疑结节。

结论

我们的研究显示V804M突变患者的预后相对较好。尽管手术在年龄较大时进行,但未观察到进展期疾病。

相似文献

1
Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.与家族性甲状腺髓样癌相关的V804M突变型RET原癌基因的特征分析:最大的土耳其家族报告
J Endocrinol Invest. 2015 May;38(5):541-6. doi: 10.1007/s40618-014-0224-0. Epub 2014 Dec 12.
2
Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.土耳其遗传性甲状腺髓样癌中RET突变的分布及治疗方法评估
J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):13-20. doi: 10.4274/jcrpe.2219. Epub 2015 Dec 18.
3
A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.挪威2A型多发性内分泌腺瘤病的全国性研究:甲状腺髓样癌临床病程的预测和预后因素
Thyroid. 2016 Sep;26(9):1225-38. doi: 10.1089/thy.2015.0673. Epub 2016 Aug 11.
4
Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.2A 型多发性内分泌腺瘤病家系中 RET 密码子 804 突变患者预防性甲状腺切除术的经验。
Clin Endocrinol (Oxf). 2005 Dec;63(6):636-41. doi: 10.1111/j.1365-2265.2005.02394.x.
5
Medullary thyroid cancer with RET V804M mutation: more indolent than expected?伴有RET V804M突变的甲状腺髓样癌:比预期更惰性?
Surgery. 2023 Jan;173(1):260-267. doi: 10.1016/j.surg.2022.05.005. Epub 2022 Sep 21.
6
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.
7
When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?对于携带RET密码子609突变的患者,何时需要进行预防性甲状腺切除术?
Ann Surg Oncol. 2009 Aug;16(8):2237-44. doi: 10.1245/s10434-009-0524-3. Epub 2009 May 27.
8
One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?107名家庭成员存在转染期间重排的V804M原癌基因突变,表现为同时患有甲状腺髓样癌和乳头状癌、罕见的原发性甲状旁腺功能亢进,且无嗜铬细胞瘤:这是一种新的综合征——MEN 2C吗?
Surgery. 2009 Dec;146(6):998-1005. doi: 10.1016/j.surg.2009.09.021.
9
Current understanding and management of medullary thyroid cancer.当前对甲状腺髓样癌的认识和管理。
Oncologist. 2013;18(10):1093-100. doi: 10.1634/theoncologist.2013-0053. Epub 2013 Sep 13.
10
Catecholamine crisis as a first manifestation of familial bilateral pheochromocytoma caused by RET proto-oncogene mutation in codon C 634R.儿茶酚胺危象作为密码子C 634R处RET原癌基因突变所致家族性双侧嗜铬细胞瘤的首发表现。
Endokrynol Pol. 2015;66(5):462-8. doi: 10.5603/EP.2015.0056.

引用本文的文献

1
RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report.地中海地区甲状腺髓样癌患者的RET原癌基因变异:简要报告
Life (Basel). 2023 Jun 6;13(6):1332. doi: 10.3390/life13061332.
2
Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical Diagnosis and Management of Medullary Thyroid Carcinoma.意外的致病性RET p.V804M变异导致甲状腺髓样癌的临床诊断与管理
Am J Case Rep. 2020 Dec 27;21:e927415. doi: 10.12659/AJCR.927415.

本文引用的文献

1
Association of RET genetic polymorphisms and haplotypes with papillary thyroid carcinoma in the Portuguese population: a case-control study.葡萄牙人群中RET基因多态性和单倍型与甲状腺乳头状癌的关联:一项病例对照研究
PLoS One. 2014 Oct 17;9(10):e109822. doi: 10.1371/journal.pone.0109822. eCollection 2014.
2
RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.2型多发性内分泌腺瘤病和家族性甲状腺髓样癌的RET基因突变(基因型和表型)
Cancer. 2014 Jul 1;120(13):1920-31. doi: 10.1002/cncr.28661. Epub 2014 Apr 3.
3
Progression of medullary thyroid cancer in RET carriers of ATA class A and C mutations.
甲状腺髓样癌在ATA A类和C类RET突变携带者中的进展。
J Clin Endocrinol Metab. 2014 Feb;99(2):E286-92. doi: 10.1210/jc.2013-3343. Epub 2013 Jan 1.
4
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.多发性内分泌腺瘤病 2 型和家族性甲状腺髓样癌:更新。
J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6.
5
The involvement of the RET variant G691S in medullary thyroid carcinoma enlightened by a meta-analysis study.一项荟萃分析研究阐明了 RET 变异体 G691S 在甲状腺髓样癌中的作用。
Int J Cancer. 2013 Jun 15;132(12):2808-19. doi: 10.1002/ijc.27967. Epub 2012 Dec 27.
6
Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.甲状腺髓样癌 (MTC) 和 RET 原癌基因:家族性病例的突变谱和散发性病例研究的荟萃分析。
Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8.
7
Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation.单个核苷酸多态性作为修饰因子,与 RET V804M 原癌基因突变的 2 个大型非相关家族中的髓样和同时髓样/乳头甲状腺癌的发展相关。
Surgery. 2010 Dec;148(6):1274-80; discussion 1280-1. doi: 10.1016/j.surg.2010.09.004.
8
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.美国癌症联合委员会:第 7 版 AJCC 癌症分期手册与 TNM 的未来。
Ann Surg Oncol. 2010 Jun;17(6):1471-4. doi: 10.1245/s10434-010-0985-4.
9
One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?107名家庭成员存在转染期间重排的V804M原癌基因突变,表现为同时患有甲状腺髓样癌和乳头状癌、罕见的原发性甲状旁腺功能亢进,且无嗜铬细胞瘤:这是一种新的综合征——MEN 2C吗?
Surgery. 2009 Dec;146(6):998-1005. doi: 10.1016/j.surg.2009.09.021.
10
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.美国甲状腺协会修订的甲状腺结节和分化型甲状腺癌患者管理指南。
Thyroid. 2009 Nov;19(11):1167-214. doi: 10.1089/thy.2009.0110.